| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |